These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3668708)

  • 1. Impact of education on cephalosporin prescribing patterns.
    Frye CB; Baker B; Sexton DJ; Dougherty FK
    J Okla State Med Assoc; 1987 Sep; 80(9):649-53. PubMed ID: 3668708
    [No Abstract]   [Full Text] [Related]  

  • 2. Changing prescribing patterns: a program of physician education.
    Whiteside ME; Lefkowitz S; Justiniani FR; Ratzan K
    Hosp Formul; 1987 Jun; 22(6):561-3, 566, 568. PubMed ID: 10282249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An approach to regulating cephalosporin use and costs.
    Ryan JL; Francese J
    Hosp Formul; 1980 Sep; 15(9):674-6. PubMed ID: 10248357
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a P & T Committee letter to influence dosing.
    Lipman AG
    Hosp Formul; 1987 Mar; 22(3):309, 312. PubMed ID: 10281732
    [No Abstract]   [Full Text] [Related]  

  • 9. Cephalosporins: use review and cost analysis.
    Noel MW; Paxinos J
    Am J Hosp Pharm; 1978 Aug; 35(8):933-5. PubMed ID: 677139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting the cost-effective utilization of cefoxitin with a drug use education program.
    Wein PJ; Hoffman RP
    Hosp Formul; 1987 Mar; 22(3):299-306. PubMed ID: 10312016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
    Simon WA; Thompson L; Campbell S; Lantos RL
    Am J Hosp Pharm; 1975 Nov; 32(11):1116-21. PubMed ID: 1190230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a cephalosporin education program--a pharmacy education program.
    Sohn CA; Wolter HA; McSweeney GW
    Drug Intell Clin Pharm; 1980 Apr; 14(4):272-7. PubMed ID: 10309192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an education program on cefazolin prescribing.
    Blain L; O'Brodovich M
    Can J Hosp Pharm; 1989 Apr; 42(2):69-71. PubMed ID: 10292923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coping with DRGs: Baptist Medical Center of Oklahoma, Oklahoma City.
    Osborne JA
    Am J Hosp Pharm; 1983 Sep; 40(9):1506-7. PubMed ID: 6414300
    [No Abstract]   [Full Text] [Related]  

  • 16. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug control program used to cut costs.
    Ollis LN; Britton HL
    Healthc Financ Manage; 1984 May; 38(5):98-100. PubMed ID: 10315555
    [No Abstract]   [Full Text] [Related]  

  • 18. A cost effective approach to surgical antibiotic prophylaxis.
    Pavan MM; Malyuk DL
    Can J Hosp Pharm; 1992 Aug; 45(4):151-6. PubMed ID: 10123058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A survey of cephalosporin use. Monitoring use in a hospital setting.
    Arthurson SL; Turnidge JD; Odgers CL
    Med J Aust; 1979 Oct; 2(8):436-9. PubMed ID: 318492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.